Obstetrics, Gynecology and Reproduction

Advanced search


Full Text:


The article represents peculiarities of the origination and treatment of surgical menopause at women of reproductive age, principles of monitoring and approaches to the hormonal therapy. In spite of the high efficiency of the therapy of menopausal disorders by estrogen containing substances there are diseases, for which its systemic administration is restricted. The supplement of the local therapy with physicotherapeutic influence in tissues allows to reduce the pain syndrome, to reduce the length of the treatment and to obtain the earlier restoration of the vagina mucous membrane.

About the Authors

V. A. Kulavskii
Bashkir State Medical University
Russian Federation

MD, Professor, head of Department of obstetrics and gynecology, Institute of additional professional education,

ul. Lenina, 3, Ufa, 450008

E. V. Kulavskii
Bashkir State Medical University
Russian Federation

PhD, associate professor of Department of obstetrics and gynecology, Institute of additional professional education,

ul. Lenina, 3, Ufa, 450008

A. M. Ziganshin
Bashkir State Medical University
Russian Federation

PhD, assistant of Department of obstetrics and gynecology, Institute of additional professional education,

ul. Lenina, 3, Ufa, 450008


1. Blinov D.V., Zimovina U.V., Sandakova E.A., Ushakova T.I. Magnesium deficiency of patients with hormone dependent diseases: pharmacoepidemiological profile and life quality assessment. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2015;8(2): 16-24. (In Russ.) DOI:10.17749/2070-4909.2015.8.2.016-024

2. Gynecological Endocrinology (ed. V. Serov VN Prilepskaya, GV Ovsyannikova) [Ginekologicheskaya endokrinologiya (pod red. V.N. Serova, V.N. Prilepskoi, G.V. Ovsyannikovoi) (in Russian)]. Moscow. 2015.

3. Ziganshin A.M., Fatkullina I.B. Lechenie i profilaktika. 2016; 2 (18): 5-10.

4. Menopause medicine (ed. Smetnik VP) [Meditsina klimakteriya (pod red. V.P. Smetnik) (in Russian)]. Yaroslavl'. 2006; 848 s.

5. Menopausal hormone therapy and maintaining the health of a woman of mature age. The introduction of women in perimenopausal and postmenopausal women. Clinical guidelines. [Menopauzal'naya gormonoterapiya i sokhranenie zdorov'ya zhenshchiny zrelogo vozrasta. Vvedenie zhenshchin v peri- i postmenopauze. Klinicheskie rekomendatsii (in Russian)]. Moscow. 2014; 57 s.

6. Kulavskii V.A., Ziganshin A.M. Rossiiskii vestnik akushera-ginekologa. 2009; 4 (9): 36-40.

7. Likhachev A.V., Galyanskaya E.G., Shevlyagina L.S., Polyanskaya I.B. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction. 2008; 1: 4-6.

8. Naber K.G., Bishop M.S., Bierklund-Iokhansen T.E. Recommendations for the management of patients with kidney infections, urinary tract and the male reproductive organs – EAU [Rekomendatsii po vedeniyu bol'nykh s infektsiyami pochek, mochevykh putei i muzhskikh polovykh organov – EAU (in Russian)]. Smolensk. 2008; 224 c.

9. Nevmerzhitskaya I.Yu., Khamoshina M.B., Plaksina N.D., Pogasov A.G. Pech. Vestnik RUDN. 2009; 5: 101-107.

10. Ovsyannikova O.V., Kulikov I.A. Meditsinskii sovet. 2015; 9: 66-70.

11. Ovsyannikova T.V., Makarov I.O., Kulikov I.A. Akusherstvo, ginekologiya i reproduktsiya / Obstetrics, gynecology and reproduction. 2013; 3: 26-29.

12. Pan Gi Mun. Message on the International Day of Older Persons [Poslanie po sluchayu Mezhdunarodnogo dnya pozhilykh lyudei (in Russian)]. URL: http: // Accessed: 28.09.2016.

13. Plaksina N.D., Simonovskaya Kh.Yu. Status Praesens. 2014; 2(19); 60-65.

14. Ponomarenko G.N. Physiotherapy: national leadership [Fizioterapiya: natsional'noe rukovodstvo (in Russian)]. Moscow. 2009; 864 s.

15. Practical recommendations. Keeping women in the peri- and post-menopausal. Ed. VP Smetnik [Prakticheskie rekomendatsii. Vedenie zhenshchin v peri- i v postmenopauze. Pod red. V.P. Smetnik (in Russian)]. Moscow. 2010; 221 s.

16. Radzinskii V.E., Khamoshina M.B., Mel'nikova G.G. Doktor. Ru. 2009; 6 (50): 21-27.

17. Salov I.A., Khashaeva T.Kh., Duganova M.O. i dr. Akusherstvo i ginekologiya. 2010; 6: 65-68.

18. Smetnik V.P., Il'ina L.M. Klimakterii. 2009; 1: 8-13.

19. Khamoshina M.B., Mel'nikova G.G., Nevmerzhitskaya I.Yu. Status Praesens. 2009; 1 (2): 63-71.

20. Yureneva S.R., Dubrovina A.V. Medica mente. 2015; 1: 26-34.

21. Assessment and management of cardiovascular risks in women. URL: http// Accessed: 28.09.2016.

22. Al.-Boghdadi O., Ewies A.A. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overviev. Climacteric. 2009; 12 (2): 91-105.

23. Buhling K.J., Daniels B.V., Studnitz F.S. et al. The use complementary and alternative medicine by women transitioning through menopause in Germany: results of a survey of women aged 45-60 years. Complement Ther. Med. 2014; 22 (1): 94-98.

24. Ceylan B., Ozerdogan N. Menopausal symptoms and guality of life in Turkish women in the climacteric period. Climacteric. 2014; 1-18.

25. Calleia-Agius J., Brincat M.P., Urogenital atrophy. Climacteric. 2009; 12 (4); 275-285.

26. Chlebowski R.T., Anderson G.L., Menopausal hormone therapy and cancer: Changing clinical observations of target site specificity. Steroids. 2014; 14: 125-131.

27. Cody J.D., Richardson K., Moehrer B., Hextall A., Glazener C.M. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2009; 7 (4).

28. Cornu J.N., Merlet B., Cussenot O., Cancel-Tassin G., Amarenco G., Haab F. Genetic susceptibility to urinary incontinence: implication of polymorphisms of androgen and oestrogen pathways. World J Urol. 2011; 29 (2): 239-242.

29. G.K.P., Arounassalame B The guality of life during and after menopause among rural women. J. Clin. Diagn. Res. 2013; 7 (1): 135-139.

30. Herber-Gast G.-C.M., Mishra G.D. Early severe vasomotor menopausal symptoms are associated with diabetes. Menopause. 2014; 21 (8): 167-172.

31. Moreira A.C., Silva A.M., Santos M.S., Sardao V.A. Phytoestrogens as alternative hormone replacement therapy in menopause: What is real, what is unknown. J. Steroid Biochem Mol. Biol. 2014; 28 (143): 61-71.

32. Mujeeb F., Bajpai P., Pathak N. Phytochemical Evaluation, Antimicrobial Activity, and Determination of Bioactive Components from Leaves of Aegle marmelos. Biomed Res Int. 2014; 29 (144): 45-49.

33. Nisar N., Sohoo N.A. Freguency of menopausal symptoms and impact on the guality of life of women:a hospital based survey. J. Pac Med. Assoc. 2009; 59 (11): 752-756.

34. Ohmichi M., Tasaka al. Molecular mechanism of action of Selective Estrogen Receptor Modulator in target tissues. J. Endocr. 2005; 52 (2): 161-167.

35. Pitkin J. Alternative and complementary therapies for the menopause. Menopause Int. 2012; 18 (1): 20-27.

36. Raz R., Stamm W. E. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. New Engl. J. Med. 1993; 329: 753-6.

37. Santen R.J. et al. Endocrine Society. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J. Clin. Endocrinol. Metab. 2010; 95 (71): 346-352.

38. Sood R., Faubion S.S., Kuhle C.L. et al. Prescribing menopausal hormone therapy: an evidence-based approach. Int. J. Womens Health. 2014; 6: 47-57.

39. Tsai S.A., Stefanick M.L., Stafford R.S. Trends in menopausal hormone therapy use of US office based physicians, 2000-2009. Menopause. 2011; 8: 385-392.

40. Villiers T.J., Gass M.L.S., Haines C.J. Global Consensus Statement on Menopausal Hormone Therapy. Climacteric. 2013; 16: 203-204.


For citations:

Kulavskii V.A., Kulavskii E.V., Ziganshin A.M. SURGICAL MENOPAUSE IN WOMEN OF REPRODUCTIVE AGE. Obstetrics, Gynecology and Reproduction. 2016;10(4):105-113. (In Russ.)

Views: 566

ISSN 2313-7347 (Print)
ISSN 2500-3194 (Online)